Extensive screening system using suspension array technology to detect mitochondrial DNA point mutations

Mitochondrion

Volumn 10, Issue 3, 2010, Pages 300-308

  Nishigaki, Yutaka ^a   Ueno, Hitomi ^a   Coku, Jorida ^b   Koga, Yasutoshi ^c   Fujii, Tatsuya ^d   Sahashi, Ko ^e   Nakano, Kazutoshi ^f   Yoneda, Makoto ^g   Nonaka, Michiko ^h   Tang, Linya ⁱ   Liou, Chia Wei ⁱ   Paquis Flucklinger, Veronique ^j   Harigaya, Yasuo ^k   Ibi, Tohru ^e   Goto, Yu ichi ^l   Hosoya, Hiroko ^a   DiMauro, Salvatore ^b   Hirano, Michio ^b   Tanaka, Masashi ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b New York Presbyterian Columbia University Medical Center   (United States)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SHIGA MEDICAL CENTER FOR CHILDREN   (Japan)

^e AICHI MEDICAL UNIVERSITY   (Japan)

^f TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^g UNIVERSITY OF FUKUI   (Japan)

^h Hyogo Prefectural Tsukaguchi Hospital   (Japan)

ⁱ CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^j UNIVERSITÉ CÔTE D'AZUR   (France)

^k MAEBASHI RED CROSS HOSPITAL   (Japan)

^l NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

more..

Author keywords

MELAS; Mitochondria; MtDNA; Pathological mutation; Suspension array

Indexed keywords

MITOCHONDRIAL DNA; PRIMER DNA;

5' UNTRANSLATED REGION; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE AMPLIFICATION; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; MUTANT; MUTATIONAL ANALYSIS; OLIGONUCLEOTIDE PROBE; POINT MUTATION; PRIORITY JOURNAL; WILD TYPE;

DNA PRIMERS; DNA, MITOCHONDRIAL; GENETIC TESTING; HUMANS; POINT MUTATION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 77949912763     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2010.01.003     Document Type: Article

References (43)

1. Anderson S., Bankier A.T., Barrell B.G., de Bruijn M.H., Coulson A.R., Drouin J., Eperon I.C., Nierlich D.P., Roe B.A., Sanger F., et al. Sequence and organization of the human mitochondrial genome. Nature 1981, 290:457-465.
2. Andreu A.L., Hanna M.G., Reichmann H., Bruno C., Penn A.S., Tanji K., Pallotti F., Iwata S., Bonilla E., Lach B., et al. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. New Engl. J. Med. 1999, 341:1037-1044.
3. Andrews R.M., Kubacka I., Chinnery P.F., Lightowlers R.N., Turnbull D.M., Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat. Genet. 1999, 23:147.
4. Bannwarth S., Procaccio V., Rouzier C., Fragaki K., Poole J., Chabrol B., Desnuelle C., Pouget J., Azulay J.P., Attarian S., et al. Rapid identification of mitochondrial DNA (mtDNA) mutations in neuromuscular disorders by using surveyor strategy. Mitochondrion 2008, 8:136-145.
5. Cassandrini D., Calevo M.G., Tessa A., Manfredi G., Fattori F., Meschini M.C., Carrozzo R., Tonoli E., Pedemonte M., Minetti C., et al. A new method for analysis of mitochondrial DNA point mutations and assess levels of heteroplasmy. Biochem. Biophys. Res. Commun. 2006, 342:387-393.
6. Chinnery P.F., Johnson M.A., Wardell T.M., Singh-Kler R., Hayes C., Brown D.T., Taylor R.W., Bindoff L.A., Turnbull D.M. The epidemiology of pathogenic mitochondrial DNA mutations. Ann. Neurol. 2000, 48:188-193.
7. de Vries D.D., van Engelen B.G., Gabreels F.J., Ruitenbeek W., van Oost B.A. A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. Ann. Neurol. 1993, 34:410-412.
8. Diaz M.R., Boekhout T., Theelen B., Bovers M., Cabanes F.J., Fell J.W. Microcoding and flow cytometry as a high-throughput fungal identification system for Malassezia species. J. Med. Microbiol. 2006, 55:1197-1209.
9. Dunbar S.A. Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection. Clin. Chim. Acta 2006, 363:71-82.
10. Elliott H.R., Samuels D.C., Eden J.A., Relton C.L., Chinnery P.F. Pathogenic mitochondrial DNA mutations are common in the general population. Am. J. Hum. Genet. 2008, 83:254-260.
11. Fuku N., Park K.S., Yamada Y., Nishigaki Y., Cho Y.M., Matsuo H., Segawa T., Watanabe S., Kato K., Yokoi K., et al. Mitochondrial haplogroup N9a confers resistance against type 2 diabetes in Asians. Am. J. Hum. Genet. 2007, 80:407-415.
12. Goto Y., Nonaka I., Horai S. A mutation in the tRNA(Leu) (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990, 348:651-653.
13. Holt I.J., Harding A.E., Petty R.K., Morgan-Hughes J.A. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. Hum. Genet. 1990, 46:428-433.
14. Johns D.R., Neufeld M.J., Park R.D. An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy. Biochem. Biophys. Res. Commun. 1992, 187:1551-1557.
15. Kadowaki T., Kadowaki H., Mori Y., Tobe K., Sakuta R., Suzuki Y., Tanabe Y., Sakura H., Awata T., Goto Y., et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. New Engl. J. Med. 1994, 330:962-968.
16. Leveque M., Marlin S., Jonard L., Procaccio V., Reynier P., Amati-Bonneau P., Baulande S., Pierron D., Lacombe D., Duriez F., et al. Whole mitochondrial genome screening in maternally inherited non-syndromic hearing impairment using a microarray resequencing mitochondrial DNA chip. Eur. J. Hum. Genet. 2007, 15:1145-1155.
17. Maitra A., Cohen Y., Gillespie S.E., Mambo E., Fukushima N., Hoque M.O., Shah N., Goggins M., Califano J., Sidransky D., et al. The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection. Genome Res. 2004, 14:812-819.
18. Majamaa K., Moilanen J.S., Uimonen S., Remes A.M., Salmela P.I., Karppa M., Majamaa-Voltti K.A., Rusanen H., Sorri M., Peuhkurinen K.J., et al. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am. J. Hum. Genet. 1998, 63:447-454.
19. Manwaring N., Jones M.M., Wang J.J., Rochtchina E., Howard C., Mitchell P., Sue C.M. Population prevalence of the MELAS A3243G mutation. Mitochondrion 2007, 7:230-233.
20. Mashima Y., Nagano M., Funayama T., Zhang Q., Egashira T., Kudho J., Shimizu N., Oguchi Y. Rapid quantification of the heteroplasmy of mutant mitochondrial DNAs in Leber's hereditary optic neuropathy using the invader technology. Clin. Biochem. 2004, 37:268-276.
21. McFarland R., Taylor R.W., Turnbull D.M. The neurology of mitochondrial DNA disease. Lancet Neurol. 2002, 1:343-351.
22. Meierhofer D., Mayr J.A., Ebner S., Sperl W., Kofler B. Rapid screening of the entire mitochondrial DNA for low-level heteroplasmic mutations. Mitochondrion 2005, 5:282-296.
23. Nishigaki Y., Marti R., Copeland W.C., Hirano M. Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J. Clin. Invest. 2003, 111:1913-1921.
24. Nishigaki Y., Yamada Y., Fuku N., Matsuo H., Segawa T., Watanabe S., Kato K., Yokoi K., Yamaguchi S., Nozawa Y., et al. Mitochondrial haplogroup A is a genetic risk factor for atherothrombotic cerebral infarction in Japanese females. Mitochondrion 2007, 7:72-79.
25. Nishigaki Y., Yamada Y., Fuku N., Matsuo H., Segawa T., Watanabe S., Kato K., Yokoi K., Yamaguchi S., Nozawa Y., et al. Mitochondrial haplogroup N9b is protective against myocardial infarction in Japanese males. Hum. Genet. 2007, 120:827-836.
26. Pakendorf B., Stoneking M. Mitochondrial DNA and human evolution. Annu. Rev. Genom. Hum. Genet. 2005, 6:165-183.
27. Pavlakis S.G., Phillips P.C., DiMauro S., De Vivo D.C., Rowland L.P. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann. Neurol. 1984, 16:481-488.
28. Prezant T.R., Agapian J.V., Bohlman M.C., Bu X., Oztas S., Qiu W.Q., Arnos K.S., Cortopassi G.A., Jaber L., Rotter J.I., et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat. Genet. 1993, 4:289-294.
29. Schaefer A.M., Taylor R.W., Turnbull D.M., Chinnery P.F. The epidemiology of mitochondrial disorders - past, present and future. Biochim. Biophys. Acta 2004, 1659:115-120.
30. Shoffner J.M., Lott M.T., Lezza A.M., Seibel P., Ballinger S.W., Wallace D.C. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990, 61:931-937.
31. Sotiriou E., Coku J., Tanji K., Huang H.B., Hirano M., DiMauro S. The m.3244G>A mutation in mtDNA is another cause of progressive external ophthalmoplegia. Neuromuscular Disord. 2009, 19:297-299.
32. Suzuki S., Oka Y., Kadowaki T., Kanatsuka A., Kuzuya T., Kobayashi M., Sanke T., Seino Y., Nanjo K. Clinical features of diabetes mellitus with the mitochondrial DNA 3243 (A-G) mutation in Japanese: maternal inheritance and mitochondria-related complications. Diabetes Res. Clin. Pract. 2003, 59:207-217.
33. Tanaka M., Cabrera V.M., Gonzalez A.M., Larruga J.M., Takeyasu T., Fuku N., Guo L.J., Hirose R., Fujita Y., Kurata M., et al. Mitochondrial genome variation in eastern Asia and the peopling of Japan. Genome Res. 2004, 14:1832-1850.
34. Tanaka M., Fuku N., Nishigaki Y., Matsuo H., Segawa T., Watanabe S., Kato K., Yoko K., Ito M., Nozawa Y., et al. Women with mitochondrial haplogroup N9a are protected against metabolic syndrome. Diabetes 2007, 56:518-521.
35. Taylor R.W., Morris A.A., Hutchinson M., Turnbull D.M. Leigh disease associated with a novel mitochondrial DNA ND5 mutation. Eur. J. Hum. Genet. 2002, 10:141-144.
36. Tiranti V., D'Agruma L., Pareyson D., Mora M., Carrara F., Zelante L., Gasparini P., Zeviani M. A novel mutation in the mitochondrial tRNA(Val) gene associated with a complex neurological presentation. Ann. Neurol. 1998, 43:98-101.
37. Ueno H., Nishigaki Y., Kong Q.P., Fuku N., Kojima S., Iwata N., Ozaki N., Tanaka M. Analysis of mitochondrial DNA variants in Japanese patients with schizophrenia. Mitochondrion 2009, 9:385-393.
38. van Den Bosch B.J., de Coo R.F., Scholte H.R., Nijland J.G., van Den Bogaard R., de Visser M., de Die-Smulders C.E., Smeets H.J. Mutation analysis of the entire mitochondrial genome using denaturing high performance liquid chromatography. Nucleic Acids Res. 2000, 28:E89.
39. Vandebona H., Mitchell P., Manwaring N., Griffiths K., Gopinath B., Wang J.J., Sue C.M. Prevalence of mitochondrial 1555A→G mutation in adults of European descent. New Engl. J. Med. 2009, 360:642-644.
40. Wallace D.C., Singh G., Lott M.T., Hodge J.A., Schurr T.G., Lezza A.M., Elsas L.J., Nikoskelainen E.K. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988, 242:1427-1430.
41. White H.E., Durston V.J., Seller A., Fratter C., Harvey J.F., Cross N.C. Accurate detection and quantitation of heteroplasmic mitochondrial point mutations by pyrosequencing. Genet. Test. 2005, 9:190-199.
42. Ye F., Li M.S., Taylor J.D., Nguyen Q., Colton H.M., Casey W.M., Wagner M., Weiner M.P., Chen J. Fluorescent microsphere-based readout technology for multiplexed human single nucleotide polymorphism analysis and bacterial identification. Hum. Mutat. 2001, 17:305-316.
43. Yoneda M., Tanno Y., Horai S., Ozawa T., Miyatake T., Tsuji S. A common mitochondrial DNA mutation in the t-RNA(Lys) of patients with myoclonus epilepsy associated with ragged-red fibers. Biochem. Int. 1990, 21:789-796.